ANIX insider transaction filings
Anixa Biosciences Inc — 26 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-03. Screen ANIX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-03 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 5,000 @ $3.47 | EDGAR |
| 2026-07-29 | 4 | Baskies Arnold M — Director | Option exercise (M): 6,000 @ $3.13 · Tax withholding (F): 5,428 @ $3.46 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 5,000 @ $3.44 | EDGAR |
| 2026-07-27 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 3,188 @ $3.37 | EDGAR |
| 2026-07-27 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 3,000 @ $3.73 | EDGAR |
| 2026-07-21 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 5,000 @ $3.46 | EDGAR |
| 2026-07-20 | 4 | Titterton Lewis H jr — Director | Purchase (P): 12,000 @ $3.47 | EDGAR |
| 2026-07-16 | 4 | Titterton Lewis H jr — Director | Purchase (P): 2,797 @ $3.28 | EDGAR |
| 2026-07-13 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 5,000 @ $3.04 | EDGAR |
| 2026-06-17 | 4 | Titterton Lewis H jr — Director | Purchase (P): 2,836 @ $2.64 | EDGAR |
| 2026-06-16 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 21,000 @ $2.50 | EDGAR |
| 2026-01-29 | 4 | Baskies Arnold M — Director | Purchase (P): 10,000 @ $3.04 | EDGAR |
| 2026-01-06 | 4 | Gottschalk Emily — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Catelani Michael — President, COO & CFO | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Baskies Arnold M — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Titterton Lewis H jr — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Titterton Lewis H jr — Director | Option exercise (M): 16,000 @ $2.92 · Option exercise (M): 16,000 (derivative) @ $0 | EDGAR |
| 2025-10-31 | 4 | KUMAR AMIT — Chief Executive Officer | Option exercise (M): 200,000 @ $2.92 · Tax withholding (F): 169,439 @ $4.06 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | Titterton Lewis H jr — Director | Purchase (P): 10,000 @ $3.08 | EDGAR |
| 2025-07-31 | 4 | KUMAR AMIT — Chief Executive Officer | Purchase (P): 5,000 @ $3.16 | EDGAR |
| 2025-07-21 | 4 | Baskies Arnold M — Director | Purchase (P): 5,000 @ $3.39 | EDGAR |
| 2025-07-15 | 4 | Titterton Lewis H jr — Director | Purchase (P): 10,000 @ $3.14 | EDGAR |
| 2025-07-14 | 4 | KUMAR AMIT — Chief Executive Officer | Purchase (P): 5,000 @ $3.15 | EDGAR |
| 2025-06-05 | 4 | KUMAR AMIT — Chief Executive Officer | Purchase (P): 10,000 @ $2.85 | EDGAR |
| 2025-01-29 | 4 | Baskies Arnold M — Director | Purchase (P): 5,000 @ $2.82 | EDGAR |
Recent 8-K events — Anixa Biosciences Inc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-03-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ANIX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →